Rosso A, Juliusson G, Lorenz F, Lehmann S, et al. Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study. Leuk Lymphoma 2021;62:1973-1981.
PMID: 33719843